W&C Advises NHSc on Mevalia and Comidamed brands acquisition

White & Case LLP has advised Nestlé Health Science (NHSc) on the acquisition of the Mevalia and Comidamed brands from Dr. Schär AG

Vitaflo (International) Limited, part of Nestlé Health Science, and Dr. Schär AG have entered into an agreement whereby Vitaflo will acquire the Dr. Schär products for Inborn Errors of Metabolism (IEM) as well as the manufacturing facility in Rosbach, Germany. The acquired brands, Mevalia and ComidaMed, are used for the dietary management of IEM and cow’s milk protein allergy and will complement Vitaflo’s existing IEM product portfolio and geographic footprint, offering more choice and variety to meet different customer needs.

“It can be very challenging for people to manage IEM dietary requirements on a day-to-day basis. Our mission is to make this as easy as possible, creating clinical nutrition products which taste great and are easy to incorporate into a busy life” said Caroline Charlesworth, CEO of Vitaflo.

“For almost 100 years we have committed to improving the lives of people with special nutritional needs. Nestlé Health Science shares our passion for health and wellbeing and with this integration of the business within Vitaflo we are positive that they will continue our successful journey in Metabolic Nutrition. This gives us the opportunity to focus even more on inclusive nutrition and gluten-free with the rest of our global brands portfolio,” said Philipp Schoeller, CEO of Dr. Schär AG.

The business operated under the two brands in, among others, Italy, Russia, the UK and Spain, and the production facility in Rosbach, Germany will be acquired by NHSc’s business unit Vitaflo. The parties have agreed not to disclose the financial details of the transaction.

Switzerland-based NHSc is a globally managed business unit of Nestlé and employs more than 7,000 people worldwide. Its products are available in more than 140 countries.

The White & Case team that advised NHSc on the transaction was led by Frankfurt partner Ingrid Wijnmalen and included partners Leonardo Graffi (Milan), Irina Dmitrieva (Moscow), Laura Hoyland and Tom Matthews (both London), local partners Carlos Daroca (Madrid, pictured) and Tim Bracksiek (Frankfurt), and associates Agmal Bahrami, Micha Gersdorf, Jan Lampert, Mathias Bogusch, Sandra D’Ascenzo (all Frankfurt), Kristin Brüggert (Hamburg), Giulia Fiorelli (Milan), Alexander Karmalita, Evgeny Chernyavsky (both Moscow), Christian Holbrook and Alexander Miles-Dinham (both London).

Desire Vidal